Presenter:
John Garrison
Vice President, Analytical Sciences and Site Head Elion Labs
KBI Biopharma
Overview
In this webinar, Dr. Garrison explores how CD is used to characterise protein higher-order structures, ensuring product safety, efficacy, and quality. He delves into quantitative approaches for assessing protein structural similarity and highlights the importance of robust analytical methods in regulatory applications.
Key Insights:
• The principles of CD spectroscopy and its role in analysing protein secondary and tertiary structures.
• Enhanced data accuracy through dual-polarising prisms and solid-state detector technology.
• Applications of CD in studying protein-ligand interactions and biopharmaceutical stability.
• Case studies illustrating the use of CD spectroscopy for structural analysis in protein-based therapies.
Discover how Dr. Garrison’s expertise transforms the use of circular dichroism in biopharmaceutical research!
